Home
Syngene International Ltd Share Price History
Syngene International Ltd
NSE : 12 Feb, 2025
709.45-12.7 (-1.8%)
Prev Close
722.2
Open Price
726.5
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
636162
Today's High / Low
734.7 / 705.0
52 WK High / Low
960.6 / 607.7
Market Price of Syngene International Ltd
1M
1Y
3Y
5Y
Monitoring Syngene International Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2018 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 15.27 |
| YoY Gr. | - |
| Net Profit (Cr.) | 305 |
| BVPS | 86.02 |
Key Financial Parameters
| Parameter | 2018 |
|---|---|
| Return on Capital Emp. % | 15.16 |
| Op. Profit Mgn % | 37 |
| Net Profit Mgn % | 21.46 |
| Debt to Equity % | 0.46 |
Latest Shareholding
Promoters Holdings Over Time
About Syngene International Ltd
- Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
- Headquartered in India, the operations are driven by its highly qualified teams comprising ~6000 scientists and its state-of-the-art facilities, spread over 2.2 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
- The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
- The Company's health-related services extend across all major therapeutic areas and modalities.
Popular Search
FAQs for Syngene International Ltd Share Price History
What are the key events that typically impact Syngene International Ltd's share price history?
Key events that impact Syngene International Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Syngene International Ltd's share price history?
Stock splits reduce the nominal price of Syngene International Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Syngene International Ltd?
Dividends can influence Syngene International Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Syngene International Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Syngene International Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Syngene International Ltd’s share price history?
To understand Syngene International Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
